Literature DB >> 15460443

Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos.

Gao Li1, Ming-Lu Xu, Chong-Soon Lee, Mi-Hee Woo, Hyun-Wook Chang, Jong-Keun Son.   

Abstract

The bioactivity-guided fractionation of the methylene chloride extract of the sclerotium of Poria cocos led to the isolation of (S)-(+)-turmerone (1), ergosterol peroxide (2), polyporenic acid C (3), dehydropachymic acid (4), pachymic acid (5), and tumulosic acid (6). Compounds 4-6 exhibited moderate cytotoxicities, with IC50 values of 20.5, 29.1, and 10.4 microM, respectively, against a human colon carcinoma cell line. However, 3-6 not only showed inhibitory activities as potent as etoposide used as a positive control on DNA topoisomerase II (36.1, 36.2, 43.9 and 66.7% inhibition at a concentration of 20 microM, respectively), but also inhibition of DNA topoisomerase I (55.8, 60.7, 43.5, and 83.3% inhibition at a concentration of 100 microM, respectively).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460443     DOI: 10.1007/BF02980174

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method.

Authors:  Xiaoran Ma; Jibiao Wu; Cun Liu; Jie Li; Shixia Dong; Xiaolu Zhang; Jia Wang; Lijuan Liu; Xiaoming Zhang; Peng Sun; Jing Zhuang; Changgang Sun
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-09       Impact factor: 2.629

2.  Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells.

Authors:  Yueguang Chen; Peilong Lian; Yanfeng Liu; Kesen Xu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Pachymic Acid Enhances Pentobarbital-Induced Sleeping Behaviors via GABAA-ergic Systems in Mice.

Authors:  Vikash Kumar Shah; Jae Joon Choi; Jin-Yi Han; Mi Kyeong Lee; Jin Tae Hong; Ki-Wan Oh
Journal:  Biomol Ther (Seoul)       Date:  2014-07       Impact factor: 4.634

4.  Chungsimyeonja-eum inhibits inflammatory responses in RAW 264.7 macrophages and HaCaT keratinocytes.

Authors:  Hye-Sun Lim; Kim Yeji; Chang-Seob Seo; Sae-Rom Yoo; Seong-Eun Jin; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  BMC Complement Altern Med       Date:  2015-10-16       Impact factor: 3.659

5.  Antileukemic Scalarane Sesterterpenoids and Meroditerpenoid from Carteriospongia (Phyllospongia) sp., Induce Apoptosis via Dual Inhibitory Effects on Topoisomerase II and Hsp90.

Authors:  Kuei-Hung Lai; Yi-Chang Liu; Jui-Hsin Su; Mohamed El-Shazly; Chih-Fung Wu; Ying-Chi Du; Yu-Ming Hsu; Juan-Cheng Yang; Ming-Kai Weng; Chia-Hua Chou; Guan-Yu Chen; Yu-Cheng Chen; Mei-Chin Lu
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

6.  Expression of Hepatic Cytochrome P450s in Rats Administered with Guibi-tang, a Traditional Herbal Formula.

Authors:  Seong Eun Jin; Hyekyung Ha; Chang-Seob Seo; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

Review 7.  Pharmacological profiles and therapeutic applications of pachymic acid (Review).

Authors:  Chunyong Wei; Hezhen Wang; Xun Sun; Zhixun Bai; Jing Wang; Guohui Bai; Qizheng Yao; Yingshu Xu; Lei Zhang
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

8.  Poria cocos Extract from Mushrooms Stimulates Aquaporin-3 via the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Sung-Gu Park; Il-Joo Jo; Seol-A Park; Min-Cheol Park; Yeun-Ja Mun
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15

9.  Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.

Authors:  Man-Gang Lee; Yi-Chang Liu; Yi-Lun Lee; Mohamed El-Shazly; Kuei-Hung Lai; Shou-Ping Shih; Seng-Chung Ke; Ming-Chang Hong; Ying-Chi Du; Juan-Cheng Yang; Ping-Jyun Sung; Zhi-Hong Wen; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2018-06-10       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.